GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Pre-Tax Income

Emcure Pharmaceuticals (NSE:EMCURE) Pre-Tax Income : ₹6,702 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Emcure Pharmaceuticals's pretax income for the three months ended in Dec. 2024 was ₹2,299 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was ₹6,702 Mil. Emcure Pharmaceuticals's pretax margin was 11.71%.

During the past 4 years, Emcure Pharmaceuticals's highest Pretax Margin was 16.87%. The lowest was 11.05%. And the median was 14.73%.


Emcure Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Emcure Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Pre-Tax Income Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
8,406.97 9,725.48 7,472.15 7,272.28

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial 1,980.25 1,709.58 1,669.04 2,734.10 2,299.19

Competitive Comparison of Emcure Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Emcure Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emcure Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emcure Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Emcure Pharmaceuticals's Pre-Tax Income falls into.


;
;

Emcure Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Emcure Pharmaceuticals's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=9558.63+0+-2287.74+207.59+-206.2
=7,272

Emcure Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2649.36+0+-317.78+0+-32.39
=2,299

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,702 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Emcure Pharmaceuticals  (NSE:EMCURE) Pre-Tax Income Explanation

Emcure Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=2299.19/19626.3
=11.71%

During the past 4 years, Emcure Pharmaceuticals's highest Pretax Margin was 16.87%. The lowest was 11.05%. And the median was 14.73%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Emcure Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Emcure Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines